top of page

Our Story

bioAerium is an innovative provider of cutting-edge patent-pending technologies for the detection of airborne viruses, including SARS-CoV-2, influenza, and RSV. Co-Founded in 2021 by Michael Caffrey, Igor Paprotny and Nitin Jayakumar of University of Illinois at Chicago. Dr. Caffrey brings outstanding expertise in  Biochemistry, Structural Biology and Virology. Dr. Paprotny brings unique expertise in air microfluidic devices that detect airbone particulate matter, including viruses. Together, the teams bring unique and powerful perspectives to the field of airborne pathogen detection. Why not join our fast growing client base? Get in touch today to learn more.

Home: About Us


Protecting your AirSpace since 2021

Home: Welcome

Our Innovative Technology

At bioAerium, we provide comprehensive technological solutions for the detection of airborne viruses and the adaptation of assays to portable and wearable devices. Our platform has a wide range of features that were created with an aim to help you live differently. In order to empower our users to do better, bioAerium is continually building upon its technology, so stay in touch to learn about upgrades and other changes.

For the detection of airborne viruses, optimal sensitivity is required. In the latest version of bioAerium we use a LAMP-based approach that enables detection of less than 10 copies of virus. A comparison of the competing technologies is given below.

Screenshot 2023-07-18 at 6.26.26 PM.png
Home: Our Technology

Rapid Response to Emerging Pathogens

Importantly, the use of LAMP as opposed to high affinity binding techniques (ELISA or SPR using antibodies or engineered antibodies or nanobodies) enables a rapid response to emerging pathogens. A comparison of the relative response times from discovery to incorporation in a detector is given below.

Screenshot 2023-07-17 at 10.29.18 AM.png
Home: Text
Home: Quote

Publications by the bioAerium Team

Home: Feature

Thanks for submitting!

Home: Contact
bottom of page